| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 76.70B | 76.01B | 72.74B | 68.80B | 62.47B | 58.10B |
| Gross Profit | 16.60B | 16.57B | 14.04B | 12.14B | 11.63B | 12.78B |
| EBITDA | 7.85B | 7.49B | 5.64B | 3.39B | 4.34B | 5.77B |
| Net Income | 5.27B | 5.10B | 2.81B | 1.29B | 896.00M | 1.32B |
Balance Sheet | ||||||
| Total Assets | 118.34B | 122.86B | 126.19B | 116.29B | 113.93B | 107.79B |
| Cash, Cash Equivalents and Short-Term Investments | 32.24B | 35.86B | 33.32B | 30.51B | 35.03B | 31.70B |
| Total Debt | 4.04B | 3.12B | 2.97B | 2.08B | 2.59B | 2.80B |
| Total Liabilities | 38.53B | 39.22B | 43.87B | 38.24B | 35.27B | 30.28B |
| Stockholders Equity | 79.81B | 83.64B | 82.32B | 78.04B | 77.99B | 76.82B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 5.66B | 1.95B | -3.04B | 4.22B | 6.21B |
| Operating Cash Flow | 0.00 | 6.51B | 3.17B | -1.13B | 5.91B | 7.26B |
| Investing Cash Flow | 0.00 | -1.83B | -1.99B | -1.88B | -2.83B | -1.92B |
| Financing Cash Flow | 0.00 | -3.76B | -1.13B | -2.17B | -1.53B | -3.77B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥85.71B | 136.93 | 5.02% | 3.23% | -10.00% | -51.92% | |
74 Outperform | ¥55.40B | 24.26 | ― | 2.54% | 2.00% | 39.80% | |
74 Outperform | ¥80.53B | 14.21 | 9.39% | 1.68% | 9.27% | 69.52% | |
69 Neutral | ¥65.00B | 10.78 | 7.00% | 3.02% | 15.78% | ― | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥27.13B | -53.89 | ― | 3.56% | -3.85% | -45.64% | |
61 Neutral | ¥279.39B | 8.88 | 7.67% | 0.91% | 9.03% | 10.76% |